Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism autotaxin inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H31F6NO3 |
InChIKeyPZASAAIJIFDWSB-BFWXTJNGSA-N |
CAS Registry1548743-66-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Preclinical | US | 14 Jun 2021 |